Nypro to establish medical device manufacturing facility in Ireland, create over 200 jobs

Friday, March 29, 2013 11:57 AM

Nypro Healthcare, a global solutions provider, plans to establish an additional state-of-the-art medical device manufacturing facility in Waterford, Ireland. This newly established facility will result in the creation of over 200 new high-quality jobs in phase I, which is expected to increase in subsequent years.

Nypro's new facility will manufacture advanced respiratory and injectable devices for global healthcare and pharmaceutical customers. Among the new positions to be created are healthcare automation engineers and technicians, healthcare quality engineers and technicians, operations managers, program managers, team leaders and operators.

“Nypro has operated in Ireland in Bray since 1980 and in recent years our healthcare business has grown significantly,” said James O' Gorman, vice president of drug delivery and diagnostics, Nypro Healthcare. “Our latest growth phase is built upon the skills, work ethic, creativity and drive of our Nypro Ireland team. We now plan to create over 200 positions in Waterford to manufacture complex respiratory and injection devices for our pharmaceutical customers worldwide. I would like to thank Nypro Inc., the Irish Government, IDA, Waterford City Council, FAS and our Nypro Ireland team for their continued support and look forward to further growth of our Irish operations in future years."

Richard Bruton, TD, minister for jobs, enterprise and innovation, added, "Today's announcement that Nypro, a world-leading company with established operations in Ireland, is locating a new state-of-the-art manufacturing facility in Waterford with the creation of over 200 high-end jobs is an enormous boost for the region. It is also a further significant boost for employment in Ireland as we continue to implement our action plan for jobs.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs